Acute monoblastic leukemia

Below you will find more information about Acute monoblastic leukemia from Medigest. If you believe that you are suffering from any of the symptoms of Acute monoblastic leukemia it is important that you obtain an accurate diagnosis from a medical professional to ensure that you obtain the correct medication or treatment for your condition. There are medical conditions that carry similar symptoms associated with Acute monoblastic leukemia and therefore the information provided by Medigest is offered as a guideline only and should never be used in preference to seeking professional medical advice. The information relating to Acute monoblastic leukemia comes from a third party source and Medigest will not be held liable for any inaccuracies relating to the information shown.


Acute monoblastic leukemia otherwise known as acute monocytic leukemia is an acute type of myeloid leukemia. For patients to be considered a victim of AML-M5, he must have more than 20% blasts in the marrow. Monoblasts are largely distinguished for displaying a rough, circular nucleus and a delicate lacy chromatin.


The first clue of AML includes abnormal result of the patient's blood count. AML also presents isolated decrease in red blood cells, platelets and even an abnormally low white blood cell count. A bone marrow examination can also be performed to further identify the type of blood cells that have displayed abnormality.


Like other forms of blood cancer, AML treatment would largely consist of chemotherapy, which is divided into two phases: the induction and postremission therapy. Induction is administered to induce complete and lasting remission by reducing the leukemic cells to untraceable levels. Consolidation aims to eliminate any existing or residual diseases.

Symptoms and Signs

Among the usual indicators of acute monoblastic leukemia include asthenia or generalized weakness, pallor, unexplained fever, dizziness and other respiratory symptoms.


There are a number of risk factor that were identified that largely contribute to the development of AML. Among these include pre-leukemic blood disorders, exposure to chemotherapy, ionizinf radiation, occupation chemical exposure, and some congenital conditions such as Down syndrome.

Discuss Acute monoblastic leukemia in our forums

Discuss Acute monoblastic leukemia with other members of Medigest in our forums.